Latest Enterprise software Startup Funding Rounds
Software companies helping organisations run their operations, serve customers and get work done.
- Rounds
- 2,282 Jan 1 – Oct 25, 2026
- Disclosed funding
- $126.9B 1915 disclosed amounts
- Median round
- $15M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| R ReactorCompany profile Developer platform providing infrastructure for real-time generative video and interactive world models Developer platform providing infrastructure for real-time generative video and interactive world models | $59M | Undisclosed | Enterprise software, AI | United States | Investors | |
| S AI-native marketing agency accelerating pharma commercialization | $21M | Series A | Enterprise software, Healthtech | United States | Investors | |
| GS Go SwagCompany profile Builds AI-powered corporate gifting and branded merchandise platform for global brands Builds AI-powered corporate gifting and branded merchandise platform for global brands | $5M | Seed | Enterprise software | United Kingdom | Investors | |
| P PublicitCompany profile Self-service omnichannel programmatic advertising platform for small and medium-sized businesses Self-service omnichannel programmatic advertising platform for small and medium-sized businesses | €700K | Pre-SeedPre-seed | Enterprise software | Spain | Investors | |
| O Builds agentic decisioning layer for CTV advertising | $10M | Series A | Enterprise software | France | Investors | |
| EL Ember LifeSciencesCompany profile Reusable temperature-controlled shipping platform for pharmaceutical cold chain distribution Reusable temperature-controlled shipping platform for pharmaceutical cold chain distribution | $27M | Series A | Enterprise software, Healthtech | United States | Investors | |
| ST Secretome TherapeuticsCompany profile Clinical-stage company developing neonatal cardiac progenitor cell therapies for Duchenne-associated cardiomyopathy Clinical-stage company developing neonatal cardiac progenitor cell therapies for Duchenne-associated cardiomyopathy | $30M | Series A | Enterprise software, Biotech | United States | Investors | |
| R RevEng.AICompany profile Provides binary-level AI analysis of compiled software to detect hidden vulnerabilities and supply chain threats Provides binary-level AI analysis of compiled software to detect hidden vulnerabilities and supply chain threats | $15M | Series A | Enterprise software, Cybersecurity | United Kingdom | Investors | |
| PB Protuoso BiosciencesCompany profile Develops AI-enabled multifunctional biologics platform targeting cardiometabolic, oncology, and autoimmune diseases Develops AI-enabled multifunctional biologics platform targeting cardiometabolic, oncology, and autoimmune diseases | $9.5M | Seed | Enterprise software, Biotech | United States | Investors | |
| AI Arken InnovationsCompany profile Builds governed decision intelligence for regulated industries using a probabilistic-retrieval and governance engine Builds governed decision intelligence for regulated industries using a probabilistic-retrieval and governance engine | Undisclosed | StrategicUndisclosed | Enterprise software, AI | Canada | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Blacksmith, Databuddy Analytics, Clueso
108rounds1led - 2General Catalyst
Legora, Different, Melius
63rounds7led - 3Lightspeed
Different, Zenzap, Zomint
60rounds3led - 4Andreessen Horowitz (a16z)
ASI, Town, EliseAI
59rounds6led - 5Accel
Coast, Legora, RapidCanvas
49rounds3led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.